ISRG INTUITIVE SURGICAL INC
What matters nowUpdated 6 h ago
- Latest: the da Vinci 5 received a CE mark for adult cardiac surgery in Europe, covering coronary artery bypass, according to trade press reporting on September 25, 2026 1. Earlier in September the da Vinci SP won a CE mark for transvaginal gynecologic procedures 2, and da Vinci 5 was introduced in India on September 18 3.
- The stock traded at 422.73 on the pooled 24/7 venue price, down 1.06% from the previous close of 427.24. Recent large moves were +3.48% on October 5, -5.27% on September 8, -6.13% on August 20 and +5.56% on August 3.
- Fundamentals for the twelve months to June 30, 2026: revenue of $11.03 billion, up 20.7% year on year, gross margin of 66.7%, operating margin of 31.3% and EPS of $8.72, up 21.4%. At a $149.6 billion market cap the stock trades on 48.5 times earnings with a 2.2% free cash flow yield. Second-quarter placements reached 468 da Vinci systems versus 395 a year earlier, 246 of them da Vinci 5, lifting the installed base to 11,710.
- Insiders sold about $8.08 million of stock over the last 180 days across 34 planned sales and bought none. Controller Fredrik Widman sold 1,089 shares at $374.44 on September 15 under a 10b5-1 plan 4.
- Next: Q3 2026 earnings and the conference call are expected on October 21, 2026 at 20:30 UTC, not yet confirmed, and Q4 and full-year results are expected on January 26, 2027. The September CPI release is due October 14 at 12:30 UTC. Polymarket odds for the October 2026 Fed meeting put no change at 81.5% and a 25 bp hike at 17.5%.
MedTech Dive · Sep 25
MedTech Dive · Sep 15
Business Wire India (via UNI) · Sep 18
SEC EDGAR, Form 4 · Sep 15
Valuation & fundamentalsFull financials →
TTM through 2026-06-30 from SEC filings (some quarters derived from annual and year-to-date figures). Ratios use our pooled 24/7 price. Quarterly statements →
Every venue
| Venue | Price | vs pool | 24h vol | Open int. | Funding 8h |
|---|---|---|---|---|---|
| okx perp ISRG-USDT-SWAP · just now | 422.44 | +0.06% | $37.4K | $88.4K | 0.0000% |
| bitget perp ISRGUSDT · just now | 421.35 | −0.19% | $27.5K | $54.9K | 0.0000% |
| bybit perp ISRGUSDT · just now | 422.45 | +0.07% | $12.2K | $40.3K | 0.0000% |
Pooled price = volume-weighted median of venues within 2% of each other. Venue markets for stocks, indices and gold are 24/7 perpetual contracts; they track but are not the official exchange price.
Open interest, 120 days
US$ millions, all venues
Funding, 120 days
Annualised %, OI-weighted. Positive: longs pay shorts.
NewsAll news →
da Vinci 5 receives CE mark for adult cardiac surgery in Europe
The da Vinci 5 system has received a CE mark for adult cardiac surgery in Europe, including coronary artery bypass procedures, according to trade press reporting on September 25, 2026.
Intuitive introduces da Vinci 5 in India with a focused rollout
Intuitive announced a focused introduction of da Vinci 5 in India, letting selected hospitals and programs build experience with the platform.
da Vinci SP gets CE mark for transvaginal gynecologic procedures in Europe
Europe's CE mark now covers the da Vinci SP single-port system for transvaginal gynecologic procedures, which the company describes as a world first for the platform.
Controller Fredrik Widman exercises options and sells 1,089 shares
Fredrik Widman, vice president and corporate controller, exercised 546 and 543 stock options and sold the same number of shares at $374.44 on September 15, 2026.
Brosius sells 77 shares on August 20 and 21 at $396.37 and $375.57
Mark Brosius sold 77 shares on each of August 20 and August 21, 2026, at $396.37 and $375.57.
Brosius sells 77 shares a day on August 17 to 19 under trading plan
Mark Brosius sold 77 shares on each of August 17, 18 and 19, 2026, at prices between about $390 and $394.
EVP Mark Brosius sells 28 shares on each of July 30 and 31
Mark Brosius, an executive vice president in charge of manufacturing and supply chain, sold 28 shares on each of July 30 and July 31, 2026.
Intuitive Surgical reports fiscal Q2 2026 results: revenue $2.89B, up 19% from a year earlier
Intuitive Surgical filed a Form 8-K with the SEC on Jul 16, 2026, 4:05 PM ET, reporting an event dated Jul 16, 2026.
Intuitive sets 2026 da Vinci procedure growth guide at 13.5% to 15.5%
For full-year 2026, Intuitive expects da Vinci procedure growth of about 13.5% to 15.5%, with the company expecting to land closer to the midpoint.
Medtronic files 510(k)s to expand Hugo into general surgery and gynecology
On June 3, 2026 Medtronic said it had submitted 510(k) filings with the FDA to expand its Hugo robotic-assisted surgery system into general and gynecologic specialties in the U.S.
Taylor Patton named Chief Commercial and Marketing Officer effective July 1
Intuitive appointed Taylor Patton, previously global senior vice president of its endoluminal business, as chief commercial and marketing officer effective July 1, 2026.
Intuitive rolls out more than 100 da Vinci 5 upgrades, starting in the U.S. in June
Intuitive announced more than 100 updates and user-experience improvements for da Vinci 5.
Board lifts share repurchase authorization to $5.0 billion
On April 30, 2026 the board increased the authorized amount under the common stock repurchase program to an aggregate of $5.0 billion, including amounts still remaining under earlier authorizations.
Intuitive Q1 2026 revenue up 23% to $2.77 billion; raises 2026 procedure and margin guidance
Intuitive reported first-quarter 2026 revenue of $2.77 billion, up 23%, with non-GAAP EPS of $2.50 and GAAP EPS of $2.28.
Intuitive completes purchase of da Vinci and Ion distributors in Italy, Spain and Portugal
Intuitive completed its acquisition of the da Vinci and Ion distribution business run by ab medica, Abex and Excelencia Robótica.